Cellebrite Di Ltd. share price logo

Cellebrite Di Ltd. Share Price

NASDAQ: CLBT

Mid Cap

$15.31

+0.12

(+0.82%)

as on

Cellebrite Di Ltd. Stock Performance

as on March 7, 2026 at 7:59 am IST

  • Day's Low

    Day's High

    $14.75
    $15.46
    downward going graph

    3.66%

    Downside

    0.98%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $11.76
    $20.86
    downward going graph

    23.19%

    Downside

    36.25%

    Upside

    downward going graph

Cellebrite Di Ltd. share price movements today

Previous Close
$15.19
Open
$14.99
Volume
1.2M
Day's Low - High
$14.75 - $15.46
52 Week Low - High
$11.76 - $20.86

Cellebrite Di Ltd. Historical Returns

1 Month Return
+ 7.2 %
3 Month Return
-16.9 %
1 Year Return
-13.15 %
3 Year Return
+ 149.84 %
5 Year Return
0 %

Cellebrite Di Ltd. Stock Fundamentals & Key Indicators

Check Cellebrite Di Ltd. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.5B

EPS (TTM)

0.552

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.02%

PE Ratio (TTM)

45.68

Industry PE ratio

30.128278688524592

PEG Ratio

0

EBITDA

78.3M

Revenue (TTM)

475.7M

Profit Margin

16.47%

Return On Equity TTM

19.10%

Cellebrite Di Ltd. Stock Valuation

Track how Cellebrite Di Ltd. P/E has moved over time to understand its valuation trends.

Cellebrite Di Ltd. in the last 5 years

  • Overview

  • Trends

Lowest (16.54x)

December 31, 2022

Industry (30.13x)

March 6, 2026

Today (45.68x)

March 6, 2026

Highest (70.28x)

September 30, 2021

LowHigh

Today’s Price to Earnings Ratio: 45.68x

Cellebrite Di Ltd. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cellebrite Di Ltd. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$3.5BNA45.6816.47%
HOLD$366.4B537.45%243.1636.31%
BUY$102.8B132.72%476.42-6.88%
BUY$129.4B192.46%88.0912.96%
BUY$437.9B121.22%28.6425.28%

Stock Returns calculator for Cellebrite Di Ltd. Stock including INR - Dollar returns

The Cellebrite Di Ltd. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Cellebrite Di Ltd. investment value today

Current value as on today

₹92,901

Returns

₹7,099

(-7.1%)

Returns from Cellebrite Di Ltd. Stock

₹12,464 (-12.46%)

Dollar Returns*

₹5,365 (+5.36%)

Analyst Recommendation on Cellebrite Di Ltd. Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Cellebrite Di Ltd.. Average target price of $21.67

Cellebrite Di Ltd. Share Price Target

Get share price movements and forecasts by analysts on Cellebrite Di Ltd..

What analysts predicted

29.35%UPSIDE

Target Price

$21.67

Current Price

$15.31

Analyzed by

14 Analysts

Target

$21.67

Cellebrite Di Ltd. target price $21.67, a slight upside of 29.35% compared to current price of $15.31. According to 14 analysts rating.

Cellebrite Di Ltd. Stock’s Investor Sentiment and Interest

Search interest for Cellebrite Di Ltd. Stock has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-33% versus previous 30 day period

Cellebrite Di Ltd. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
84
93
89
95
106
109
107
113
126
128
Gross Profit
71
78
76
79
91
91
90
95
105
109
Operating Income
13
14
9
12
19
15
12
14
18
20
EBITDA
15
17
11
15
22
18
14
17
26
24
Interest Expense
6
78
78
34
223
1
-
-
-
-
Depreciation
2
2
2
2
2
2
2
2
2
-
Income Before Tax
6
-12
-69
-22
-204
19
19
20
24
26
Income Tax Expense
0
2
2
1
2
0
1
1
4
5
Net Income
6
-14
-71
-23
-207
19
17
19
20
21
Net Profit Margin
7.72%
-15.75%
-79.67%
-24.88%
-193.80%
17.67%
16.18%
17.19%
16.02%
16.50%

Cellebrite Di Ltd. Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
171
194
246
270
325
401
475
Gross Profit
136
157
203
219
271
338
400
Operating Income
-1
9
13
1
33
56
66
EBITDA
5
17
89
130
-64
67
78
Interest Expense
0
1
0
0
0
349
-
Depreciation
4
5
7
9
9
10
-
Income Before Tax
1
11
82
120
-75
-275
90
Income Tax Expense
3
5
10
0
5
7
12
Net Income
-1
5
71
120
-81
-283
78
Net Profit Margin
-1.09%
2.97%
28.99%
44.63%
-24.95%
-70.54%
16.47%

Cellebrite Di Ltd. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-14
-71
-23
-207
19
17
19
20
21
Operating Cash Flow
43
10
14
41
65
20
32
33
82
Investing Cash Flow
3
-81
-33
-18
-15
-126
40
63
-246
Financing Cash Flow
4
5
3
5
6
3
13
5
6
Change in Cash
52
-67
-15
29
55
-101
88
102
-156

Cellebrite Di Ltd. Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
5
71
120
-81
-283
78
Operating Cash Flow
66
36
20
102
132
168
Investing Cash Flow
-6
45
-91
-22
-149
-268
Financing Cash Flow
-8
-68
13
21
20
29
Change in Cash
52
12
-58
101
2
-67

Global Institutional Holdings in Cellebrite Di Ltd.

Funds
Holdings
Voss Capital LLC
3.29%
Granahan Investment Management Inc..
1.25%
Cooper Creek Partners Management LLC
1.24%
Handelsbanken Fonder AB
1%
Nuveen, LLC
0.88%

Cellebrite Di Ltd. News & Key Events

  • img

    Today's Timeline - 13 November

    Thu, 05:52 PM

    -

    Bank of America reiterates Buy rating on Cellebrite, highlighting recovery in Federal demand and growth potential.

    Thu, 08:52 PM

    -

    William Blair maintains Buy rating on CLBT, citing strong financial performance and promising growth prospects.

    Thu, 10:48 PM

    -

    Cellebrite stock climbs 23% after earnings beat expectations, with revenue and adjusted EBITDA also exceeding forecasts.

  • img

    Today's Timeline - 13 November

    Thu, 11:51 PM

    -

    Cellebrite reports strong Q3 results, raising full-year sales and ARR targets, boosting investor confidence.

Insights on Cellebrite Di Ltd.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, CLBT stock has moved up by 14.7%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 17.4M → 21.26M (in $), with an average increase of 6.4% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 107.54M → 128.82M (in $), with an average increase of 5.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Palantir Technologies Inc has given 1798.1% return, outperforming this stock by 1641.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Palantir Technologies Inc has given 85.1% return, outperforming this stock by 98.0%

About Cellebrite Di Ltd.

Cellebrite is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze and manage digital data.
OrganisationCellebrite Di Ltd.
Headquarters94 Shlomo Shmelzer Road, Petah Tikva, Israel, 4970602
IndustryTechnology
CEOMr. Thomas E. Hogan
E-voting on sharesClick here to vote

Key Management of Cellebrite Di Ltd.

Name

Title

Mr. Thomas E. Hogan

CEO & Director

Mr. Yossi Carmil

Founder

Mr. Chris Wade

Chief Technology Officer

Ms. Sigalit Shavit

Chief Information Officer

Ms. Holly B. Windham Esq., J.D.

General Counsel & Chief Compliance Officer

Mr. Ronnen Armon

Chief Products & Technologies Officer

Mr. Marcus Jewell

Global Chief Revenue Officer

Mr. David Barter

Chief Financial Officer

Andrew Kramer

Vice President of Investor Relations

Mr. David Nicholas Gee

Chief Marketing Officer

FAQs

What is Cellebrite Di Ltd. share price today?

Cellebrite Di Ltd. share price today is $15.31 as on at the close of the market. Cellebrite Di Ltd. share today touched a day high of $15.46 and a low of $14.75.

What is the 52 week high and 52 week low for Cellebrite Di Ltd. share?

Cellebrite Di Ltd. share touched a 52 week high of $20.86 on and a 52 week low of $11.76 on . Cellebrite Di Ltd. stock price today i.e. is closed at $15.31,which is 26.61% down from its 52 week high and 30.19% up from its 52 week low.

What is Cellebrite Di Ltd.'s market capitalisation today?

Cellebrite Di Ltd. market capitalisation is $0.00T as on .

How to invest in Cellebrite Di Ltd. Stock (CLBT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cellebrite Di Ltd. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cellebrite Di Ltd. Shares that will get you 0.0980 shares as per Cellebrite Di Ltd. share price of $15.31 per share as on March 7, 2026 at 2:29 am IST.

What is the minimum amount required to buy Cellebrite Di Ltd. Stock (CLBT) from India?

Indian investors can start investing in Cellebrite Di Ltd. (CLBT) shares with as little as ₹91.708 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.08 in Cellebrite Di Ltd. stock (as per the Rupee-Dollar exchange rate as on ). Based on Cellebrite Di Ltd. share’s latest price of $15.31 as on March 7, 2026 at 2:29 am IST, you will get 0.6532 shares of Cellebrite Di Ltd.. Learn more about fractional shares .